Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-06-14

Clinical Trial Update: The Effect of Coltect (Selenium, Curcumin and Green Tea) on Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Coltect (selenium, curcumin, and green tea) for irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coltect

Snippet

Sponsor: NAFTALI TIMNA | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: UNKNOWN